Global Hospital Acquired Infections (HAI) Diagnostics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Reagents and Analyzers.

By Infection Type;

Urinary Tract Infection (UTI), Blood Stream Infection (BSI), Surgical Site Infection (SSI), Pneumonia and Other Most Common Hospital Acquired Infections, and Hospital Acquired Infections.

By Diagnostic Test Type;

Molecular Diagnostics, and Others In-Vitro Diagnostics Tests.

By End-use;

Hospitals, Diagnostic Laboratories, Research Institutes, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn130584603 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Hospital Acquired Infections (HAI) Diagnostics Market (USD Million), 2021 - 2031

In the year 2024, the Global Hospital Acquired Infections (HAI) Diagnostics Market was valued at USD 7,942.62 million. The size of this market is expected to increase to USD 11,401.51 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.3%.

The global Hospital Acquired Infections (HAI) diagnostics market is witnessing significant growth owing to the increasing prevalence of hospital-acquired infections worldwide. Hospital-acquired infections, also known as nosocomial infections, are infections acquired by patients during their stay in healthcare facilities. These infections pose a serious threat to patient safety and can lead to prolonged hospital stays, increased healthcare costs, and even mortality in severe cases. As healthcare facilities strive to enhance infection control measures and reduce the incidence of HAIs, the demand for advanced diagnostics tools and technologies is on the rise.

One of the key factors driving the growth of the HAI diagnostics market is the increasing awareness about the importance of early detection and prevention of hospital-acquired infections. Healthcare providers are increasingly focusing on implementing effective surveillance programs and adopting rapid diagnostic tests to identify HAIs promptly. Moreover, the growing emphasis on antimicrobial stewardship programs and infection control practices is further fueling the demand for HAI diagnostics solutions. Technological advancements in diagnostic techniques are also contributing to the expansion of the HAI diagnostics market. Innovations such as molecular diagnostics, next-generation sequencing, and automation have revolutionized the detection of hospital-acquired infections, enabling faster and more accurate diagnosis. Additionally, the integration of artificial intelligence and machine learning algorithms into diagnostic platforms is enhancing their efficiency and reliability, thereby driving market growth.

The increasing incidence of multi-drug resistant infections and the emergence of novel pathogens are creating a pressing need for advanced diagnostics solutions in healthcare settings. With the continuous evolution of infectious agents and their resistance patterns, there is a growing demand for diagnostic tools that can provide rapid and comprehensive insights into the causative agents of HAIs. As a result, the global HAI diagnostics market is poised for substantial growth in the coming years, with manufacturers focusing on developing innovative solutions to address the evolving needs of healthcare providers in the fight against hospital-acquired infections.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Infection Type
    3. Market Snapshot, By Diagnostic Test Type
    4. Market Snapshot, By End-use
    5. Market Snapshot, By Region
  4. Global Hospital Acquired Infections (HAI) Diagnostics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing healthcare awareness
        2. Technological advancements in diagnostics
        3. Rising prevalence of HAIs
        4. Stringent regulations for infection control
        5. Growing demand for rapid testing
      2. Restraints
        1. High cost of diagnostic tests
        2. Limited access to healthcare
        3. Concerns regarding accuracy
        4. Resistance to antimicrobial agents
        5. Lack of skilled professionals
      3. Opportunities
        1. Emerging markets' untapped potential
        2. Development of novel diagnostic methods
        3. Collaborations for research and development
        4. Focus on preventive healthcare measures
        5. Integration of AI in diagnostics
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Hospital Acquired Infections (HAI) Diagnostics Market, By Product, 2021 - 2031 (USD Million)
      1. Urinary Tract Infection (UTI)
      2. Blood Stream Infection (BSI)
      3. Surgical Site Infection (SSI)
      4. Pneumonia
      5. Other Most Common Hospital Acquired Infections
      6. Hospital Acquired Infections
    2. Global Hospital Acquired Infections (HAI) Diagnostics Market, By Infection Type, 2021 - 2031 (USD Million)
      1. Urinary Tract Infection (UTI)
      2. Blood Stream Infection (BSI)
      3. Surgical Site Infection (SSI)
      4. Pneumonia
      5. Other Hospital Acquired Infections
    3. Global Hospital Acquired Infections (HAI) Diagnostics Market, By Diagnostic Test Type, 2021 - 2031 (USD Million)
      1. Molecular Diagnostics
      2. Others In-Vitro Diagnostics Tests
    4. Global Hospital Acquired Infections (HAI) Diagnostics Market, By End-use, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Research Institutes
      4. Others
    5. Global Hospital Acquired Infections (HAI) Diagnostics Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. bioMrieux
      2. Abbott Laboratories
      3. Alere Inc
      4. Roche AG
      5. Siemens Healthcare
      6. Becton Dickenson
      7. Cepheid Inc
      8. Thermo Fisher Scientific
      9. Seegene Inc
      10. Qiagen
  7. Analyst Views
  8. Future Outlook of the Market